The global market for Energy-based Therapeutics was valued at US$7.7 Billion in 2024 and is projected to reach US$9.5 Billion by 2030, growing at a CAGR of 3.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth of the energy-based therapeutics market is driven by several factors, foremost among them being the rising preference for minimally invasive surgeries. These procedures, characterized by shorter recovery periods and reduced risks, have become highly attractive to patients. The preference for minimally invasive procedures is driving the demand for energy-based surgical instruments and techniques. Additionally, advancements in aesthetic medicine have led to increased adoption of anti-aging treatments and energy-based aesthetic surgeries, which are not only effective but also relatively affordable. The shift from invasive to non-invasive procedures is contributing to market growth. Moreover, the trend of physician-owned ambulatory surgical centers, which offer outpatient treatments, is creating significant growth opportunities, as most energy-based procedures do not require hospitalization.
The future of energy-based therapeutics market will be influenced by ongoing technological advancements and a growing demand for non-invasive procedures. Innovations in minimally invasive laser therapies and precise targeting through advanced imaging technologies have significantly improved treatment efficacy and patient outcomes. The integration of artificial intelligence (AI) and the Internet of Things (IoT) in therapeutic devices has further personalized treatment options, optimizing energy delivery to meet individual patient needs. Additionally, there is an increasing application of energy-based therapies in fields such as oncology and cardiology, driven by their effectiveness in providing targeted treatments with minimal side effects. The aging global population and the rising prevalence of chronic diseases are also fueling market growth, as these conditions often require the precise and targeted treatment approaches that energy-based therapies can provide. This broad and expanding market continues to evolve, with regions like North America and Europe leading in adoption, while Asia-Pacific shows significant growth potential.
Global Energy-Based Therapeutics Market - Trends & Drivers Summarized
Energy-based therapeutics is a medical field that utilizes various energy forms to remove pathological tissues and modify healthy tissues for therapeutic purposes. This includes technologies like microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound. These therapies are used to destroy or change tissues and have broad applications in different medical and aesthetic procedures. Common uses include general surgeries for gynecology and lithotripsy, ophthalmic surgeries for glaucoma and cataract treatments, and aesthetic surgeries for issues such as acne and pigmentation reduction. Both invasive and non-invasive methods are employed, with the latter gaining significant traction due to their less intrusive nature and quicker recovery times, making these therapies popular worldwide.The growth of the energy-based therapeutics market is driven by several factors, foremost among them being the rising preference for minimally invasive surgeries. These procedures, characterized by shorter recovery periods and reduced risks, have become highly attractive to patients. The preference for minimally invasive procedures is driving the demand for energy-based surgical instruments and techniques. Additionally, advancements in aesthetic medicine have led to increased adoption of anti-aging treatments and energy-based aesthetic surgeries, which are not only effective but also relatively affordable. The shift from invasive to non-invasive procedures is contributing to market growth. Moreover, the trend of physician-owned ambulatory surgical centers, which offer outpatient treatments, is creating significant growth opportunities, as most energy-based procedures do not require hospitalization.
The future of energy-based therapeutics market will be influenced by ongoing technological advancements and a growing demand for non-invasive procedures. Innovations in minimally invasive laser therapies and precise targeting through advanced imaging technologies have significantly improved treatment efficacy and patient outcomes. The integration of artificial intelligence (AI) and the Internet of Things (IoT) in therapeutic devices has further personalized treatment options, optimizing energy delivery to meet individual patient needs. Additionally, there is an increasing application of energy-based therapies in fields such as oncology and cardiology, driven by their effectiveness in providing targeted treatments with minimal side effects. The aging global population and the rising prevalence of chronic diseases are also fueling market growth, as these conditions often require the precise and targeted treatment approaches that energy-based therapies can provide. This broad and expanding market continues to evolve, with regions like North America and Europe leading in adoption, while Asia-Pacific shows significant growth potential.
Report Scope
The report analyzes the Energy-based Therapeutics market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments
Technology (Laser-based Technology, Light-based Technology, Radiofrequency-based Technology, Ultrasound-based Technology, Thermal Technology, Other Technologies); Application (Aesthetic Application, Surgical Application, Ophthalmic Application); End-Use (Clinics End-Use, Hospitals End-Use, Other End-Uses).Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Laser-based Technology segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of a 3.3%. The Light-based Technology segment is also set to grow at 4.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $2.1 Billion in 2024, and China, forecasted to grow at an impressive 6.9% CAGR to reach $2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Alcon Switzerland SA, Alna-Medicalsystem AG and Co.KG, AngioDynamics, Inc., ATRICURE, Inc., BIOLASE, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Energy-based Therapeutics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Energy-based Therapeutics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Energy-based Therapeutics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 45 major companies featured in this Energy-based Therapeutics market report include:
- Alcon Switzerland SA
- Alna-Medicalsystem AG and Co.KG
- AngioDynamics, Inc.
- ATRICURE, Inc.
- BIOLASE, Inc.
- Biolitec Holding GmbH & Co KG
- Boston Scientific Corporation
- Candela Corporation
- Cutera, Inc.
- Cynosure LLC
- Dornier MedTech GmbH
- EDAP TMS SA
- LIGHTMED
- Lumenis Be Ltd.
- Medtronic
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alcon Switzerland SA
- Alna-Medicalsystem AG and Co.KG
- AngioDynamics, Inc.
- ATRICURE, Inc.
- BIOLASE, Inc.
- Biolitec Holding GmbH & Co KG
- Boston Scientific Corporation
- Candela Corporation
- Cutera, Inc.
- Cynosure LLC
- Dornier MedTech GmbH
- EDAP TMS SA
- LIGHTMED
- Lumenis Be Ltd.
- Medtronic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 387 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.7 Billion |
| Forecasted Market Value ( USD | $ 9.5 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
